BI Asset Management Fondsmaeglerselskab’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.62M | Buy |
4,984
+476
| +11% | +$250K | 0.03% | 324 |
|
|
2025
Q1 | $2.86M | Sell |
4,508
-111
| -2% | -$70.4K | 0.03% | 300 |
|
|
2024
Q4 | $3.29M | Buy |
4,619
+1,297
| +39% | +$924K | 0.03% | 277 |
|
|
2024
Q3 | $3.49M | Buy |
3,322
+120
| +4% | +$126K | 0.06% | 223 |
|
|
2024
Q2 | $3.37M | Sell |
3,202
-1,577
| -33% | -$1.66M | 0.06% | 234 |
|
|
2024
Q1 | $4.6M | Buy |
4,779
+285
| +6% | +$274K | 0.09% | 179 |
|
|
2023
Q4 | $3.95M | Sell |
4,494
-4,978
| -53% | -$4.37M | 0.08% | 187 |
|
|
2023
Q3 | $7.8M | Sell |
9,472
-10,583
| -53% | -$8.71M | 0.18% | 112 |
|
|
2023
Q2 | $14.4M | Buy |
20,055
+194
| +1% | +$139K | 0.34% | 73 |
|
|
2023
Q1 | $16.3M | Sell |
19,861
-4,727
| -19% | -$3.88M | 0.43% | 62 |
|
|
2022
Q4 | $17.7M | Buy |
24,588
+8,607
| +54% | +$6.21M | 0.47% | 61 |
|
|
2022
Q3 | $11M | Sell |
15,981
-15,689
| -50% | -$10.8M | 0.56% | 51 |
|
|
2022
Q2 | $18.7M | Buy |
31,670
+503
| +2% | +$297K | 0.8% | 38 |
|
|
2022
Q1 | $21.8M | Sell |
31,167
-6,584
| -17% | -$4.6M | 0.83% | 39 |
|
|
2021
Q4 | $23.8M | Buy |
37,751
+2,811
| +8% | +$1.78M | 0.88% | 31 |
|
|
2021
Q3 | $21.1M | Buy |
34,940
+26,201
| +300% | +$15.9M | 0.8% | 35 |
|
|
2021
Q2 | $4.88M | Sell |
8,739
-314
| -3% | -$175K | 0.19% | 116 |
|
|
2021
Q1 | $4.28M | Buy |
9,053
+87
| +1% | +$41.2K | 0.17% | 121 |
|
|
2020
Q4 | $4.33M | Buy |
8,966
+1,167
| +15% | +$564K | 0.19% | 103 |
|
|
2020
Q3 | $4.37M | Buy |
7,799
+3,487
| +81% | +$1.95M | 0.2% | 108 |
|
|
2020
Q2 | $2.69M | Buy |
+4,312
| New | +$2.69M | 0.14% | 140 |
|
|
2020
Q1 | – | Sell |
-379
| Closed | -$142K | – | 380 |
|
|
2019
Q4 | $142K | Buy |
+379
| New | +$142K | 0.01% | 299 |
|